Lilli Zülch



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

ATR inhibition in combination with hypofractionated radiotherapy is superior to ATM inhibition with regard to ex vivo CD8 + T cell activation particularly for HPV-negative head and neck cancer cells (2026) Schäfer A, Zülch L, Steinsdörfer L, Donaubauer AJ, Reichardt C, Frey B, Fietkau R, et al. Journal article Radiotherapy and DNA damage response inhibitors modestly sensitize HNSCC to NK cell killing, with ATM inhibition more effective than ATR inhibition (2026) Steinsdörfer L, Zülch L, Schäfer A, Frey B, Corradini S, Fietkau R, Gaipl U, Jost T Journal article Corrigendum: Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC (Frontiers in Oncology, (2024), 14, (1460150), 10.3389/fonc.2024.1460150) (2025) Meidenbauer J, Wachter M, Schulz S, Mostafa N, Zülch L, Frey B, Fietkau R, et al. Journal article, Erratum Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer – detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients’ peripheral blood (2024) Donaubauer AJ, Frey B, Weber M, Allner M, Vogl C, Almajali O, Kuczera L, et al. Journal article Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC (2024) Meidenbauer J, Wachter M, Schulz S, Mostafa N, Zülch L, Frey B, Fietkau R, et al. Journal article